Risk of rapid evolutionary escape from biomedical interventions targeting SARS-CoV-2 spike protein

Area of Science:

• Virology
• Immunology
• Evolutionary Biology

Background:

• The spike protein receptor-binding domain (RBD) of SARS-CoV-2 is a key target for COVID-19 vaccines and antibody therapies.
• Viral immune evasion through mutations in the RBD is a significant concern for the long-term efficacy of these interventions.

Purpose of the Study:

• To investigate the ease with which SARS-CoV-2 can escape neutralizing antibodies (nAbs) targeting the spike RBD.
• To predict the frequency and timeline of immune escape mutant emergence under different selective pressures.

Main Methods:

• Combined structure-function analysis of the RBD with an evolutionary modeling framework.
• Analyzed epitope overlap and ACE2 binding affinity of escape mutants.
• Modeled the frequency of immune escape before and after widespread nAb presence.

Main Results:

• RBD epitopes for nAbs show substantial overlap, allowing for evasion by mutants with wild-type-like ACE2 affinity.
• The fitness cost of nAb-evading mutations is low, facilitating rapid emergence.
• Evolutionary modeling predicts quick and repeated development of resistance to single or dual antibody-based interventions.

Conclusions:

• SARS-CoV-2 can rapidly develop resistance to antibody-based COVID-19 interventions due to low-fitness-cost mutations in the spike RBD.
• Predicted timelines for resistance emergence align with nAb decay kinetics, suggesting a dual mechanism for immunity loss.
• Diversifying molecular targets and therapeutic modalities is crucial for effective viral elimination strategies.